A
Adrian C Bateman
Researcher at University Hospital Southampton NHS Foundation Trust
Publications - 146
Citations - 8121
Adrian C Bateman is an academic researcher from University Hospital Southampton NHS Foundation Trust. The author has contributed to research in topics: Cancer & Neoadjuvant therapy. The author has an hindex of 42, co-authored 142 publications receiving 7188 citations. Previous affiliations of Adrian C Bateman include Royal Hampshire County Hospital & National Health Service.
Papers
More filters
Journal ArticleDOI
British Society of Gastroenterology position statement on serrated polyps in the colon and rectum
James E. East,Wendy Atkin,Adrian C Bateman,Susan K. Clark,Sunil Dolwani,Shara N Ket,Simon J. Leedham,Perminder Phull,Matthew D. Rutter,Matthew D. Rutter,Neil A. Shepherd,Ian Tomlinson,Colin J Rees +12 more
TL;DR: It is suggested that until further evidence on the efficacy or otherwise of surveillance are published, patients with sessile serrated lesions that appear associated with a higher risk of future neoplasia or colorectal cancer should be offered a one-off colonoscopic surveillance examination at 3 years.
Journal ArticleDOI
Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma
TL;DR: Preliminary results indicate that V EGF genotype may influence tumour growth in CMM, possibly via the effects of differential VEGF expression on tumour angiogenesis.
Journal ArticleDOI
Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies.
E. C. Cuevas,Adrian C Bateman,B. S. Wilkins,P. A. Johnson,J. H. Williams,A. H. S. Lee,D.B. Jones,D. H. Wright +7 more
TL;DR: Microwave antigen retrieval represents an important technical advance within immunocytochemistry that will greatly increase the range of antibodies which can be used to study formalin fixed, paraffin wax embedded tissues.
Journal ArticleDOI
Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.
TL;DR: The results suggest that the role of cytokine promoter SNPs in both susceptibility to and prognosis in breast cancer requires further investigation in a larger study.
Journal ArticleDOI
IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma
TL;DR: Results indicate that genotypes associated with high levels of IL-10 expression in vitro are protective in CMM, while low expression genotypes are a risk factor for more advanced/poorer prognosis disease and may confer susceptibility to CMM.